Lung cancer is the leading cause of cancer mortality worldwide. There have been only slight
improvements in early diagnosis and survival, reflecting limited advances in screening and …

Substantial evidence supports a functional role for cyclooxygenase‐and lipoxygenase‐
catalyzed arachidonic and linoleic acid metabolism in cancer development. Genetic …

BACKGROUND. Early stage lung cancer has a variable prognosis, and there are currently
no markers that predict which patients will recur. This study examined the relation between …

Despite recent improvements in chemotherapy and radiation therapy in cancer management
with the addition of biological agents, novel treatment approaches are needed to further …

AIM: To correlate cyclooxygenase-2 (COX-2) expression profile with clinical and
pathological variables to assess their prognostic/predictive value in colorectal carcinoma …

Background Cyclooxygenase-2 (COX-2) has been implicated in tumorigenesis and
metastasis, and it presumably mediates the proliferation of endothelial cells and promotes …

Background To evaluate the expression of EGFR and COX-2 and their correlation with
prognosis in NSCLC Methods The paraffin embedded tumor samples of 50 NSCLC patients …

Abstract Cyclooxygenase-2 (COX-2) is an enzyme that has been extensively investigated as
a prognostic marker in cancer. In non-small cell lung cancer (NSCLC) previous results …

BACKGROUND: We investigated the prognostic value of cyclooxygenase-2 (COX-2) for
survival of patients with non-small cell lung cancer (NSCLC). METHODS: We performed a …

Abstract Cyclooxygenase-2 (COX-2) is overexpressed in lung cancer, especially in
adenocarcinoma (ADC). Our aim was to determine the prognostic value of COX-2 on …